Correlation Between Genmab AS and Altria

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Altria at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Altria into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Altria Group, you can compare the effects of market volatilities on Genmab AS and Altria and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Altria. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Altria.

Diversification Opportunities for Genmab AS and Altria

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Genmab and Altria is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Altria Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altria Group and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Altria. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altria Group has no effect on the direction of Genmab AS i.e., Genmab AS and Altria go up and down completely randomly.

Pair Corralation between Genmab AS and Altria

Assuming the 90 days horizon Genmab AS is expected to under-perform the Altria. In addition to that, Genmab AS is 2.12 times more volatile than Altria Group. It trades about -0.21 of its total potential returns per unit of risk. Altria Group is currently generating about -0.02 per unit of volatility. If you would invest  4,312  in Altria Group on January 26, 2024 and sell it today you would lose (20.00) from holding Altria Group or give up 0.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Altria Group

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Altria Group 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Altria Group are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Altria may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Genmab AS and Altria Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Altria

The main advantage of trading using opposite Genmab AS and Altria positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Altria can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altria will offset losses from the drop in Altria's long position.
The idea behind Genmab AS and Altria Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Directory
Find actively traded commodities issued by global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.